Langerwehe-Hamich, Germany

Babette-Yvonne Koegel

USPTO Granted Patents = 40 


Average Co-Inventor Count = 5.0

ph-index = 8

Forward Citations = 188(Granted Patents)


Location History:

  • Langerwehe-Hamisch, DE (1998)
  • Langerwehe-Hamaich, DE (2007)
  • Langerwehe, DE (2008 - 2011)
  • Langerwehe-Hamrich, DE (2010 - 2013)
  • Langerwehe-Hamich, DE (2000 - 2019)
  • Langewehe-Hamrich, DE (2011 - 2019)

Company Filing History:


Years Active: 1998-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Analgesics
COX-II Inhibitors
Spirocyclic Compounds
Cyclohexane Derivatives
Neuropathic Pain Treatment
Inflammatory Pain Inhibition
Substituted Aminomethyl Compounds
Pharmaceutical Compositions
Substituted Indoles
Cyclic Aminomethyl Compounds
Substituted Cycloheptenes
Substituted 4-Aminocyclohexanols
40 patents (USPTO):Explore Patents

Title: The Innovative Journey of Babette-Yvonne Koegel

Introduction:

Babette-Yvonne Koegel, a visionary inventor hailing from Langerwehe-Hamich, DE, has left an indelible mark in the field of pharmaceutical innovation. With an impressive 40 patents to his name, Koegel's dedication to advancing medical treatments has revolutionized the world of pain management and medication development.

Latest Patents:

Koegel's recent patents include groundbreaking inventions such as the Combination of selected analgesics and COX-II inhibitors. This patent showcases his pioneering work in developing advanced pharmaceutical compositions for the treatment of pain. Additionally, his Substituted azaspiro(4.5)decane derivatives patent highlights his expertise in creating compounds with an affinity for opioid receptors, opening new possibilities in medicinal research.

Career Highlights:

Having worked at esteemed companies like Grunenthal GmbH, Koegel has honed his skills and expertise in the pharmaceutical industry. His contributions have not only garnered recognition but have also propelled the field forward through innovative solutions and novel approaches to drug development.

Collaborations:

Throughout his career, Koegel has collaborated with talented individuals such as Bernd Sundermann and Werner Guenter Englberger. These partnerships have been instrumental in bringing his inventive ideas to life and have laid the foundation for groundbreaking discoveries in the realm of pharmaceuticals.

Conclusion:

In conclusion, Babette-Yvonne Koegel stands as a trailblazing inventor whose passion for innovation has reshaped the landscape of pharmaceuticals. His relentless pursuit of advancements in pain management and medication development has solidified his legacy as a pioneering figure in the field. As Koegel continues to push boundaries and explore new horizons, the impact of his work will undoubtedly continue to inspire future generations of inventors and researchers in the quest for cutting-edge solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…